1.Recent research on the epidemiology and preventive strategies of neonatal group B Streptococcus infection in the latest decade.
Meng-Yang GUO ; Wei GAO ; Lin YUAN ; Kai-Hu YAO
Chinese Journal of Contemporary Pediatrics 2023;25(5):534-540
Currently, the main strategy for preventing neonatal group B Streptococcus (GBS) infection is prenatal screening combined with intrapartum antibiotic prophylaxis, which has effectively reduced the incidence of neonatal GBS early-onset disease. However, the burden of GBS infection is still significant. The intrapartum antibiotic prophylaxis strategy has limitations such as inducing antibiotic resistance and inability to effectively prevent GBS late-onset disease. It is crucial to develop and evaluate other prevention strategies, while paying close attention to assessing penicillin allergy in pregnant women and how to prevent GBS infection in neonates with negative maternal GBS screening. In recent years, there has been some progress in GBS vaccines and related immunological research, and the use of specific vaccines is expected to significantly reduce GBS infection in neonates.
Female
;
Humans
;
Infant, Newborn
;
Pregnancy
;
Anti-Bacterial Agents/therapeutic use*
;
Antibiotic Prophylaxis
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Pregnancy Complications, Infectious/epidemiology*
;
Streptococcal Infections/drug therapy*
;
Streptococcus agalactiae
2.Advances in hepatitis E epidemiology.
Xin Yue YANG ; Qi Yu HE ; Lin WANG
Chinese Journal of Hepatology 2023;31(5):455-459
Hepatitis E is a viral hepatitis that the hepatitis E virus (HEV) causes. In the early 1980s, the hepatitis E virus was first discovered and identified, and it is one of the important pathogens that cause acute viral hepatitis globally. HEV infection is usually self-limiting, but in some groups of populations, such as pregnant women, patients with chronic liver disease, and the elderly, the prognosis is poor and may result in acute or subacute liver failure or even death. In addition, HEV infection can occur in chronically immunocompromised populations. At present, some regions and countries are not paying enough attention to hepatitis E prevention, diagnosis, and treatment, which suggests that we should study the epidemiology of HEV infection.
Humans
;
Female
;
Pregnancy
;
Aged
;
Hepatitis E/epidemiology*
;
Hepatitis E virus/genetics*
;
Prognosis
;
Liver Failure
;
Pregnancy Complications, Infectious
4.Progress in research of influenza vaccination in pregnant women.
Si Meng FAN ; Xiao Kun YANG ; Hong Ting ZHAO ; Ying QIN ; Jian Dong ZHENG ; Zhi Bin PENG ; Yan Ping ZHANG ; Zi Jian FENG
Chinese Journal of Epidemiology 2023;44(7):1157-1162
Influenza is an acute respiratory infectious disease caused by influenza virus. Pregnancy is associated with physiologic and immunological changes that may increase the risk for influenza virus infection and influenza-related complications. Influenza vaccination is the most effective way to prevent influenza virus infection. WHO and many countries have classified pregnant women as a priority population for influenza vaccination, however, there are still many challenges for promoting influenza vaccination in pregnant women in China, influenza vaccination coverage in pregnant women remains low and some influenza vaccine package inserts list pregnancy as an absolute contraindication. In this paper, we summarize the research progress in the effects of influenza infection and influenza vaccination during pregnancy both at home and abroad, then discuss the strategies to promote influenza vaccination in pregnancy for the purpose of providing reference for the related research and policy development in China.
Pregnancy
;
Female
;
Humans
;
Pregnant Women
;
Influenza, Human/epidemiology*
;
Pregnancy Complications, Infectious/epidemiology*
;
Influenza Vaccines
;
Vaccination
;
Orthomyxoviridae
5.Analysis on influencing factors of HBV intrauterine transmission based on integration of decision tree model and logistic regression model.
Wen Xin CHEN ; Cong JIN ; Ting WANG ; Yan Di LI ; Shu Ying FENG ; Bo WANG ; Yong Liang FENG ; Su Ping WANG
Chinese Journal of Epidemiology 2022;43(1):85-91
Objective: To investigate the influencing factors of HBV intrauterine transmission and their interaction effects by integrating logistic regression model and Chi-squared automatic interaction detector (CHAID) decision tree model. Methods: A total of 689 pairs of HBsAg-positive mothers and their neonates in the obstetrics department of the Third People's Hospital of Taiyuan from 2007 to 2013 were enrolled, and the basic information of mothers and their neonates were obtained by questionnaire survey and medical record review, such as the general demographic characteristics, gestational week and delivery mode. HBV DNA and HBV serological markers of the mothers and newborns were detected by fluorescence quantitative PCR and electrochemiluminescence immunoassay respectively. The CHAID decision tree model and unconditional logistic regression analysis were used to explore the factors influencing HBV intrauterine transmission in neonates of HBsAg-positive mothers. Results: Among the 689 neonates, the incidence of HBV intrauterine transmission was 11.47% (79/689). After adjusted for confounding factors, the first and second logistic multivariate analysis showed that cesarean delivery was a protective factor for HBV intrauterine transmission (OR=0.25, 95%CI: 0.14-0.43; OR=0.27, 95%CI: 0.15-0.46); both models indicated that maternal HBeAg positivity and HBV DNA load ≥2×105 IU/ml before delivery were risk factors of HBV intrauterine transmission (OR=3.89, 95%CI: 2.32-6.51; OR=3.48, 95%CI: 2.12-5.71), respectively. The CHAID decision tree model screened three significant factors influencing HBV intrauterine transmission, the most significant one was maternal HBeAg status, followed by delivery mode and maternal HBV DNA load. There were interactions between maternal HBeAg status and delivery modes, as well as delivery mode and maternal HBV DNA load before delivery. The rate of HBV intrauterine transmission in newborns of HBeAg-positive mothers by vaginal delivery increased from 19.08% to 29.37%; among HBeAg-positive mothers with HBV DNA ≥2×105 IU/ml, the rate of HBV intrauterine transmission increased to 33.33% in the newborns by vaginal delivery. Conclusions: Maternal HBeAg positivity,maternal HBV DNA ≥2×105 IU/ml and vaginal delivery could be risk factors for HBV intrauterine transmission in newborns. Interaction effects were found between maternal HBeAg positivity and vaginal delivery, as well as vaginal delivery and high maternal HBV DNA load. Logistic regression model and the CHAID decision tree model can be used in conjunction to identify the high-risk populations and develop preventive strategies accurately.
DNA, Viral/genetics*
;
Decision Trees
;
Female
;
Hepatitis B Surface Antigens
;
Hepatitis B e Antigens
;
Hepatitis B virus/genetics*
;
Humans
;
Infant, Newborn
;
Infectious Disease Transmission, Vertical
;
Logistic Models
;
Mothers
;
Pregnancy
;
Pregnancy Complications, Infectious/epidemiology*
6.Guidance for the clinical management of infants born to mothers with suspected/confirmed COVID-19 in Singapore.
Kee Thai YEO ; Agnihotri BISWAS ; Selina Kah YING HO ; Juin Yee KONG ; Srabani BHARADWAJ ; Amutha CHINNADURAI ; Wai Yan YIP ; Nurli Fadhillah AB LATIFF ; Bin Huey QUEK ; Cheo Lian YEO ; Yvonne Peng MEI NG ; Kenny Teong TAI EE ; Mei Chien CHUA ; Woei Bing POON ; Zubair AMIN
Singapore medical journal 2022;63(9):489-496
In this paper, we provide guidance to clinicians who care for infants born to mothers with suspected/confirmed COVID-19 during this current pandemic. We reviewed available literature and international guidelines based on the following themes: delivery room management; infection control and prevention strategies; neonatal severe acute respiratory syndrome coronavirus 2 testing; breastfeeding and breastmilk feeding; rooming-in of mother-infant; respiratory support precautions; visiting procedures; de-isolation and discharge of infant; outpatient clinic attendance; transport of infant; and training of healthcare staff. This guidance for clinical care was proposed and contextualised for the local setting via consensus by members of this workgroup and was based on evidence available as of 31 July 2020, and may change as new evidence emerges.
Infant, Newborn
;
Pregnancy
;
Female
;
Humans
;
Mothers
;
COVID-19/epidemiology*
;
Singapore/epidemiology*
;
COVID-19 Testing
;
Pandemics/prevention & control*
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Pregnancy Complications, Infectious/prevention & control*
7.Untreated Prior Pulmonary Tuberculosis Adversely Affects Pregnancy Outcomes in Infertile Women Undergoing
Xiao Yan GAI ; Hong Bin CHI ; Lin ZENG ; Wen Li CAO ; Li Xue CHEN ; Chen ZHANG ; Ming LU ; Lan Ding NING ; Chun CHANG ; Wei Xia ZHANG ; Ping LIU ; Rong LI ; Yong Chang SUN ; Jie QIAO
Biomedical and Environmental Sciences 2021;34(2):130-138
Objective:
Prior pulmonary tuberculosis (PTB) on chest X-ray (CXR) was commonly found in infertile patients receiving examinations before
Method:
We conducted a retrospective cohort study of 14,254 infertile patients who had received IVF-ET at Peking University Third Hospital in 2017. Prior PTB was defined as the presence of signs suggestive of old or inactive PTB on CXR, with or without a clinical TB history. Patients who had prior PTB on CXR but had not received a clinical diagnosis and anti-TB therapy were included for analysis. Live birth, clinical pregnancy, and miscarriage rates were compared between the untreated PTB and non-PTB groups.
Results:
The untreated PTB group had significantly lower clinical pregnancy (31.7%
Conclusions
Untreated PTB was associated with adverse pregnancy outcomes after IVF-ET, especially in patients with unexplained infertility, highlighting the clinical significance of PTB in this specific patient population.
Abortion, Spontaneous/epidemiology*
;
Adult
;
China/epidemiology*
;
Embryo Transfer/statistics & numerical data*
;
Female
;
Fertilization in Vitro/statistics & numerical data*
;
Humans
;
Infertility, Female/etiology*
;
Live Birth/epidemiology*
;
Middle Aged
;
Pregnancy
;
Pregnancy Complications, Infectious/epidemiology*
;
Pregnancy Outcome/epidemiology*
;
Radiography, Thoracic
;
Retrospective Studies
;
Tuberculosis, Pulmonary/epidemiology*
;
Young Adult
8.Clinical characteristics of patients with listeriosis.
Chaoxia WEI ; Pengcheng ZHOU ; Qianqian YE ; Xun HUANG ; Chunhui LI ; Anhua WU
Journal of Central South University(Medical Sciences) 2021;46(3):257-262
OBJECTIVES:
To investigate the clinical characteristics of patients with listeriosis and to provide a basis for diagnosis, treatment, prevention and control of hospital infection.
METHODS:
A total of 10 inpatients, who suffered from the listeriosis in Xiangya Hospital, Central South University from January 2013 to June 2019, were retrospectively collected for this study. The characteristics of the patients' age, gander, basic information, case type, clinical manifestations, first consultation department, days of diagnosis, infection indicator, specimen type, results of drug sensitivity, treatment plan, hospital infection or not, outcome, follow-up data were analyzed.
RESULTS:
Two cases were pregnant women and other were non-pregnant adults among 10 patients with listeriosis. Among them, there were 3 cases with hospital acquired infection. The age of patient onset was 27-71 years old, and the time from onset to diagnosis was 5-36 days. Five cases had fever, and other 5 cases had not fever. There were headache, fatigue, local pain, and other specialized symptoms in the 10 patients.The white blood cell count,the neutrophil ratio, the inflammatory index C-reactive protein, the procalcitonin were all increased, and the erythrocyte sedimentation was accelerated in the 10 patients.All the patients were sensitive to ampicillin, penicillin G, meropenem, and compound sinomine.
CONCLUSIONS
Listeriosis often affects the patients with low immunity, which often leads to misdiagnosis or missed diagnosis in clinic.So early prevention, early diagnosis, and early treatment can reduce mortality; it is important for departments of nosocomial infection management to manage patients' diet for avoiding outbreaks of listeriosis in hospital.
Adult
;
Aged
;
Female
;
Humans
;
Listeria monocytogenes
;
Listeriosis/epidemiology*
;
Meropenem
;
Middle Aged
;
Pregnancy
;
Pregnancy Complications, Infectious
;
Retrospective Studies
9.Elimination of hepatitis B virus infection in children: experience and challenge in China.
Jie TANG ; Yu-Qian LUO ; Yi-Hua ZHOU
Chinese Medical Journal 2021;134(23):2818-2824
Chronic hepatitis B virus (HBV) infection is a serious health issue because of its severe sequelae. Prevention of mother-to-child transmission (MTCT) of HBV is critical to eliminate chronic HBV infection. Here, we reviewed the progress toward the elimination of HBV infection in children in China in the recent decade. A universal hepatitis B vaccination program started from 2002 has been intensified, with the coverage of timely birth dose >95% of all newborn infants from 2012. Since 2011, China has taken a nationwide program to administer hepatitis B immunoglobulin (HBIG) with free of charge in all neonates of HBV-infected mothers, leading to a significant increment of timely use of HBIG. The prevalence of hepatitis B surface antigen (HBsAg) was declined from around 10% among children in 1980s to <0.5% among children born after 2011. Administration of oral antiviral agents in HBV-infected pregnant women with HBV DNA >2 × 105 U/mL during the third trimester is increasing, which will further reduce MTCT of HBV. However, there are some challenges in the elimination of HBV infection in children, which need to overcome by the concerted efforts. Nevertheless, it is anticipated that China will achieve the goal set by the World Health Organization that the prevalence of HBsAg in children aged <5 years is ≤0.1% by 2030.
China/epidemiology*
;
Female
;
Hepatitis B/prevention & control*
;
Hepatitis B Surface Antigens
;
Hepatitis B virus
;
Hepatitis B, Chronic/prevention & control*
;
Humans
;
Infant
;
Infant, Newborn
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Pregnancy
;
Pregnancy Complications, Infectious/epidemiology*
10.Effects of Human Immunodeficiency Virus-positive Mothers Receiving Antiretroviral Therapy to Prevent Mother-to-child Transmission on the Growth and Development of 18-month-old Children in Lingshan County of Guangxi.
Xian-Min GE ; Mei LIN ; Jin-Mei CHEN ; Jin-Hui ZHU ; Guang-Hua LAN ; Yu YAN ; Huan-Huan CHEN ; Liu-Hong LUO ; Shan-Shan LI ; Bin LI ; Guang-Hua HUANG ; Jia-Wei LI ; Yue-Qin DENG ; Ping-Jing WEN ; Yu-Man HUANG ; Qiu-Ying ZHU ; Qin MENG ; Shuai-Feng LIU ; Xiu-Ling WU ; Jing-Hua HUANG ; Hua-Xiang LU
Acta Academiae Medicinae Sinicae 2021;43(5):743-748
Objective To evaluate the effects of antiretroviral therapy(ART)for the prevention of mother-to-child transmission(PMTCT)of acquired immune deficiency syndrome(AIDS)on the growth and development of 18-month-old children born by human immunodeficiency virus(HIV)-positive pregnant women in Lingshan County,Guangxi Zhuang Autonomous Region,and provide scientific evidence for improving the ART medication plan for PMTCT.Methods Lingshan County,ranking the first in the HIV-epidemic counties of Guangxi,was selected as the research site.According to the design of retrospective case-control study,we assigned all the subjects into the case group and the control group:(1)The case group included the HIV-positive pregnant women who had received ART for PMTCT and their HIV-negative infants in Lingshan County from 2010 to 2017.The historical cards and PMTCT data of them were collected from the national PMTCT database.(2)The control group included the healthy pregnant women and their healthy babies born in the Lingshan Maternity and Infant Hospital in 2017,and the children's growth and development data were collected.The stunted growth in children was defined as at least one of the three main indicators of body height,body weight,and head circumference below the normal range.Results The number of HIV-positive mothers and their infants in the case group was 391 and 368,respectively,and 87.21%(341/391)and 95.38%(351/368)of mothers and infants respectively received ART medication.The HIV positive rate,mortality rate,and mother-to-child transmission rate of 18-month-old children were 1.36%(5/368),4.35%(16/368),and 2.01%(5/249),respectively.The incidence of stunted growth of 18-month-old children in the case group and the control group was 42.12%(155/368)and 23.06%(101/438),respectively,with significant difference(
Case-Control Studies
;
China/epidemiology*
;
Female
;
Growth and Development
;
HIV
;
HIV Infections/prevention & control*
;
Humans
;
Infant
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Mothers
;
Pregnancy
;
Pregnancy Complications, Infectious/drug therapy*
;
Retrospective Studies

Result Analysis
Print
Save
E-mail